The Jenner Institute at Oxford University, together with partners Imaxio and GSK, has started a phase I clinical trial of a novel vaccine candidate aimed at blocking transmission of malaria.
Nov 9, 2015
0
44
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today.
Nov 2, 2015
0
18
The avian influenza A (H7N9) virus has been a major concern since the first outbreak in China in 2013. Due to its high rate of lethality and pandemic potential, H7N9 vaccine development has become a priority for public health ...
Sep 25, 2015
0
22
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government ...
Aug 3, 2015
1
53
A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...
Jul 30, 2015
0
72
When Anna Markowitz learned that George Washington University researchers were looking for healthy volunteers to infect with bloodthirsty hookworms, her decision was resolute.
Jul 7, 2015
0
94
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.
Jun 26, 2015
0
12
Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory ...
Jun 22, 2015
0
19
A consortium of academic and industry organizations led by a team from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) has launched a new effort to develop an entirely new type of vaccine ...
Jun 4, 2015
0
12
A vaccine against malaria, developed at Oxford University's Jenner Institute, has shown promising results in its first field trial. The results are published today in journal Science Translational Medicine.
May 7, 2015
0
104
